+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Comparative optic nerve physiology: implications for glaucoma, neuroprotection, and neuroregeneration



Comparative optic nerve physiology: implications for glaucoma, neuroprotection, and neuroregeneration



Veterinary Ophthalmology 2(1): 13-25



The axoplasm of optic nerve axons moves bidirectionally at various speeds along an intra-axonal pressure gradient from the retinal ganglion cell (RGC) somata toward its synapse, and from the synapse towards the RGC somata. The axoplasmic flow of optic nerve axons is precarious even at normal intraocular pressures (IOP) as it moves from the intraocular optic nerve through the scleral lamina cribrosa to the intraorbital optic nerve. The scleral lamina cribrosa is not simply a porous region of the sclera but a specialized extracellular matrix of the central nervous system whose movement during fluctuations in IOP can affect optic nerve axoplasmic flow. The abundant optic nerve blood supply maintains adequate optic nerve head perfusion through a process of vascular autoregulation. Glaucoma is associated with reduced optic nerve axoplasmic flow and compromised optic nerve circulation such that RGC death due to glutamate excitotoxicity and neurotrophin deprivation result.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 068747777

Download citation: RISBibTeXText

PMID: 11397239

DOI: 10.1046/j.1463-5224.1999.00048.x


Related references

Comparative optic nerve physiology: Implications for glaucoma, neuroprotection, and neuroregeneration. Veterinary Ophthalmology 2(1): 13-25, 1999

Optic nerve degeneration and potential neuroprotection: implications for glaucoma. European Journal of Ophthalmology 9(Suppl. 1): S9, 1999

Neuroprotection in Glaucoma Using Calpain-1 Inhibitors: Regional Differences in Calpain-1 Activity in the Trabecular Meshwork, Optic Nerve and Implications for Therapeutics. Cns & Neurological Disorders - Drug Targets 7(3): 295-304, 2008

Neuroprotection in glaucoma using calpain-1 inhibitors: regional differences in calpain-1 activity in the trabecular meshwork, optic nerve and implications for therapeutics. Cns and Neurological Disorders Drug Targets 7(3): 295-304, 2008

Neuroprotection of the optic nerve in glaucoma. Acta Ophthalmologica Scandinavica 75(4): 364-367, 1997

Glaucoma 2.0: neuroprotection, neuroregeneration, neuroenhancement. Ophthalmology 119(5): 979-986, 2012

Understanding optic nerve degeneration: key to neuroprotection in glaucoma. Drugs of the Future 31(4): 355-363, 2006

Vaccination for neuroprotection in the mouse optic nerve: implications for optic neuropathies. Journal of Neuroscience 21(1): 136-142, 2001

Intraocular pressure and optic nerve damages in monocular early glaucoma: a comparative study of primary open angle glaucoma and low tension glaucoma. Chinese Journal of Ophthalmology 28(4): 217-220, 1992

A ketogenic diet may offer neuroprotection in glaucoma and mitochondrial diseases of the optic nerve. Medical Hypothesis Discovery and Innovation Ophthalmology Journal 1(3): 45-49, 2012

A comparative study of optic nerve damage between primary open angle glaucoma and normal tension glaucoma. Chinese Journal of Ophthalmology 41(2): 136-140, 2005

Effects of optic nerve injury, glaucoma, and neuroprotection on the survival, structure, and function of ganglion cells in the mammalian retina. Journal of Physiology 586(18): 4393-4400, 2008

Sensory stimulation for lowering intraocular pressure, improving blood flow to the optic nerve and neuroprotection in primary open-angle glaucoma. Acupuncture in Medicine 31(4): 416-421, 2013

Neuroprotection in glaucoma: a model for neuroprotection in optic neuropathies. Current Opinion in Ophthalmology 14(6): 353-356, 2003

Experimental and clinical evidence of neuroprotection by nerve growth factor eye drops: Implications for glaucoma. Proceedings of the National Academy of Sciences of the United States of America 106(32): 13469-13474, 2009